ArticleFrontiers in oncology2025
Contrast-enhanced ultrasound findings of hepatic pseudolipoma: a case report.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatic pseudolipoma is a relatively rare benign tumor of the liver in primary hepatic lesions and is characterized by focal fat around the liver capsule. It typically affects older adult men. In this case report, we discuss the case of a 71-year-old male who presented to our hospital with rectal adenocarcinoma. A pseudolipoma was incidentally detected on a preoperative computed tomography scan of the abdomen. We performed contrast-enhanced ultrasound to clarify the nature of this tumor. To the best of our knowledge, there have not been any documented reports on contrast-enhanced ultrasound findings of hepatic pseudolipoma. Findings: Hepatic pseudolipoma appears on contrast-enhanced ultrasound as slightly hyperechoic nodule with poorly defined borders and regular morphology. Diagnosis: On the basis of the patient's clinical symptoms, test results, and imaging manifestations, the lesion was considered a pseudolipoma, not a liver metastasis from rectal cancer. Pseudolipoma usually does not need treatment. Conclusion: The current report will help enhance the current knowledge regarding identifying hepatic pseudolipoma by contrast-enhanced ultrasound imaging and review the related literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.